SMG · Scotts Miracle-Gro Co
Price & Indicators
Up next
Metrics snapshot
Useful current figures from the complete screener profile.
AI Brief
Q3 FY26 earnings call · Jul 29, 2026TL;DR. SMG reaffirmed fiscal 2026 guidance and raised its full-year non-GAAP adjusted EPS from continuing operations outlook to $4.30–$4.45 (from $4.15–$4.35), while warning Q4 U.S. consumer sales will likely land at the low end of guidance due to elevated retailer inventories and noting Q3 GAAP results were pressured by ~$64M of impairment/restructuring/severance items.
- + Raised full-year non-GAAP adjusted EPS from continuing operations guidance to $4.30–$4.45 from $4.15–$4.35
- + Year-to-date gross margin rate expanded 130 bps to 35.7%, on track for full-year non-GAAP gross margin of at least 32%
- + Year-to-date non-GAAP adjusted EBITDA up 5% to $686.6M; reaffirmed mid-single-digit growth guidance
- + Leverage ratio improved ~0.4x to 3.78x; reaffirmed full-year target of high-3s driven by $275M free cash flow
- − Q3 GAAP gross margin rate of 31.2% (non-GAAP 31.3%) declined ~90–100 bps YoY due to higher freight and commodity costs from the Iran conflict
- − Q3 GAAP net income from continuing operations of $103.6M / $1.75 per share, down 33–34% YoY, due to ~$64M of impairment, restructuring and severance charges
- − Full-year commodity costs now expected to be ~$15M above initial plan, with most recognized in Q3
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Strong SellIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.
Versus peers
Agricultural Inputs — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
SMG
this stock
Scotts Miracle-Gro Co
|
$2.96B | -14.1% | +6.2% | 42.4 | 8.1% |
|
CTVA
Corteva, Inc.
|
$52.26B | +15.8% | +2.9% | 51.2 | 3.1% |
|
NTR
Nutrien Ltd.
|
$34.47B | +13.8% | — | — | 1.6% |
|
CF
CF Industries Holdings, Inc.
|
$17.73B | +49.0% | +19.3% | 8.7 | 6.5% |
|
YARIY
Yara International ASA
|
$11.64B | +7.3% | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| SMG | -5.2% | -15.2% | -19.9% | -16.2% | -14.1% |
| SPY | -0.7% | +0.1% | +12.2% | -0.6% | +11.8% |
| vs SPY | -4.5% | -15.3% | -32.1% | -15.6% | -26.0% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.